2024;5:e519
Prodrugs, which are inactive compounds that release parent components after metabolism in vivo, have been extensively employed to enhance the effectiveness of existing antirheumatic drugs [27, 28]
Gaba, A., Mairhofer, C., Zhegu, Z., Leditznig, N., Szabo, S., Tscholakoff, B., Zinnanti, J., Lebeda, M., Petre, B
This may possibly suggest that the introduction of the peptide may have caused a proliferation of somatotroph cells, which are the natural cells with GH-producing potential in the pituitary gland
#Osteoarthritis #ClinicalTrials #Research #KnowledgeTranslation #DrugDevelopment To view or add a comment, sign in The evidence for Arthramid 2.5% iPAAG is growing, and its redefining what long-term success looks like